1. Home
  2. CTSO vs KNRX Comparison

CTSO vs KNRX Comparison

Compare CTSO & KNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.61

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

KNRX

KNOREX LTD. Class A Ordinary Shares

N/A

Current Price

$1.37

Market Cap

42.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CTSO
KNRX
Founded
1997
2009
Country
United States
Singapore
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
38.2M
42.6M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CTSO
KNRX
Price
$0.61
$1.37
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.38
N/A
AVG Volume (30 Days)
98.7K
68.0K
Earning Date
05-13-2026
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
65.79
N/A
EPS
N/A
N/A
Revenue
$22,503,908.00
N/A
Revenue This Year
$10.34
N/A
Revenue Next Year
$22.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.53
N/A
52 Week Low
$0.50
$0.76
52 Week High
$1.39
$3.45

Technical Indicators

Market Signals
Indicator
CTSO
KNRX
Relative Strength Index (RSI) 46.17 45.36
Support Level $0.50 $1.29
Resistance Level $0.74 $1.45
Average True Range (ATR) 0.05 0.20
MACD 0.00 -0.02
Stochastic Oscillator 62.45 27.32

Price Performance

Historical Comparison
CTSO
KNRX

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

Share on Social Networks: